Arama Sonuçları - Ray Li

  • Gösterilen 1 - 6 sonuçlar arası kayıtlar. 6
Sonuçları Daraltın
  1. 1
    Efficiently decodable insertion/deletion codes for high-noise and high-rate regimes

    Efficiently decodable insertion/deletion codes for high-noise and high-rate regimes Yazar: Venkatesan Guruswami, Ray Li

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Inhibitory Control and Emotional Stress Regulation: Neuroimaging Evidence for Frontal-Limbic Dysfunction in Psycho-stimulant Addiction

    Inhibitory Control and Emotional Stress Regulation: Neuroimaging Evidence for Frontal-Limbic Dysfunction in Psycho-stimulant Addiction Yazar: Ray Li, Chiang-shan, Sinha, Rajita

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim
    Metin
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Imaging Response Inhibition in a Stop-Signal Task: Neural Correlates Independent of Signal Monitoring and Post-Response Processing

    Imaging Response Inhibition in a Stop-Signal Task: Neural Correlates Independent of Signal Monitoring and Post-Response Processing Yazar: Ray Li, Chiang-shan, Huang, Cong, Constable, R. Todd, Sinha, Rajita

    Baskı/Yayın Bilgisi 2006
    Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim
    Metin
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Bosutinib versus Placebo for Autosomal Dominant Polycystic Kidney Disease

    Bosutinib versus Placebo for Autosomal Dominant Polycystic Kidney Disease Yazar: Vladimı́r Tesař, Kazimierz Ciechanowski, York Pei, Irina Barash, Megan B. Shannon, Ray Li, Jason H. Williams, Matteo Levisetti, Steven Arkin, Andreas L. Serra

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study

    PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind st... Yazar: Mark D. Pegram, Igor Bondarenko, Marina Moreira Costa Zorzetto, Sachin Hingmire, Hirotaka Iwase, Petr Krivorotko, Keun Seok Lee, Rubi K. Li, Joanna Pikiel, Rajesh Aggarwal, Reginald B. Ewesuedo, Amy Freyman, Ray Li, Alicia M. Vana, Donghua Yin, Charles Zacharchuk, Elizabeth Tan-Chiu

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors

    First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors Yazar: Michael L. Maitland, Jasgit C. Sachdev, Manish Sharma, Víctor Moreno, Valentina Boni, Shivaani Kummar, Erica Stringer-Reasor, Nehal J. Lakhani, Allison Moreau, Dawei Xuan, Ray Li, Eric L. Powell, Amy Jackson-Fisher, Michelle Bowers, Shilpa Alekar, Xiaohua Xin, Anthony W. Tolcher, Emiliano Calvo

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: